Live Evaluations
A Clinician’s Guide to Managing Hidradenitis Suppurativa: An In-depth Workshop: PANP24
About
A Clinician's Guide to Managing Hidradenitis Suppurativa: An In-depth Workshop
This activity is supported by educational grants from Incyte, Novartis Pharmaceuticals Corporation, and UCB, Inc. In partnership with the HS Foundation.
Learning Objectives
At the completion of this activity, participants should be better able to:
Describe the pathways for the development of hidradenitis suppurativa (HS)
Review emerging procedural and medical management of HS and strategies for incorporating into patient care
Discuss best practices in managing pain and wound care in HS
Develop strategies to involve patients in shared decision making
Intended Audience
Faculty
TJ Chao, MPAS, PA-C
Atlanta North Dermatology
Woodstock, GA
Jennifer Hsiao, MD
Associate Professor
Department of Dermatology, Keck School of Medicine
University of Southern California
Los Angeles, CA
Hadar Lev-Tov, MD, MAS
Associate Professor
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine
Miami, FL
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
No relevant financial relationships with any Ineligible Company in the past 24 months.
Advisory Board/Consultant: AbbVie, Aclaris, Boheringer Ingelheim, Novartis, UCB
Speaker's Bureau: Abbvie
Advisory Board: Incyte
Grant/Research Support: Vomaris, NextScience Essity, Sigvaris
Consultant: Insmed, Novartis, UCB, Molnlycke
Ownership Interest (publicly traded): Learnskin
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.